EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isolation and Characterization of Jumbo Coliphage vB_EcoM_Lh1B as a Promising Therapeutic Agent against Chicken Colibacillosis

Pavel Alexyuk iD, Andrey Bogoyavlenskiy, Madina Alexyuk, Kuralay Akanova, Yergali Moldakhanov, Vladimir Berezin

Microorganisms · 08.06.2023 · 11 (6) · 1524

DOI: 10.3390/microorganisms11061524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 08.06.2023. Verfasst von Pavel Alexyuk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Antiviral Protection, Department of Virology, Research and Production Center for Microbiology and Virology, Bogenbai Batyr Street 105, …. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science of the Republic of Kazakhstan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colibacillosis in chickens can cause the death of young stock, decrease weight gain and lead to significant economic losses. Currently, antibiotic therapy is the main method of treatment of infected animals, but unchecked use of antibiotics has led to widespread antibiotic resistance among microorganisms. Therefore, it is necessary to develop alternative methods of treating bacterial infections that are fully consistent with the One Health concept and introduce them into practice. Phage therapy meets the specified requirements perfectly. This study describes the isolation and characterization of the lytic jumbo phage vB_EcoM_Lh1B and evaluates its potential use in controlling antibiotic-resistant E. coli infection in poultry. The complete phage genome is 240,200 bp long. Open reading frame (ORF) prediction shows that the phage genome does not contain genes encoding antibiotic resistance and lysogeny factors. Based on phylogenetic and electron microscopic analysis, vB_EcoM_Lh1B belongs to the group of myoviruses of the Seoulvirus genus of the Caudoviricetes class. The bacteriophage has good resistance to a wide range of pH and temperatures and has the ability to suppress 19 out of 30 studied pathogenic E. coli strains. The biological and lytic properties of the isolated vB_EcoM_Lh1B phage make it a promising target of further study as a therapeutic agent against E. coli infections in poultry.

Schlagwörter

Stichwörter der Autor:innen

Escherichia coliantibiotic resistancebacteriophagecolibacillosispoultry farming

Autor:innen und Institutionen

  • Laboratory of Antiviral Protection, Department of Virology, Research and Production Center for Microbiology and Virology, Bogenbai Batyr Street 105, Almaty 050010, Kazakhstan.

ORCID-Profile: Pavel Alexyuk

Förderung

  • Ministry of Education and Science of the Republic of Kazakhstan

Zitieren

APA

Alexyuk, P., Bogoyavlenskiy, A., Alexyuk, M., Akanova, K., Moldakhanov, Y., & Berezin, V. (2023). Isolation and Characterization of Jumbo Coliphage vB_EcoM_Lh1B as a Promising Therapeutic Agent against Chicken Colibacillosis. Microorganisms, 11(6), 1524. https://doi.org/10.3390/microorganisms11061524

Vancouver

Alexyuk P, Bogoyavlenskiy A, Alexyuk M, Akanova K, Moldakhanov Y, Berezin V. Isolation and Characterization of Jumbo Coliphage vB_EcoM_Lh1B as a Promising Therapeutic Agent against Chicken Colibacillosis. Microorganisms. 2023;11(6):1524. doi:10.3390/microorganisms11061524

BibTeX
@article{Alexyuk2023,
  author = {Alexyuk, Pavel and Bogoyavlenskiy, Andrey and Alexyuk, Madina and Akanova, Kuralay and Moldakhanov, Yergali and Berezin, Vladimir},
  title = {Isolation and Characterization of Jumbo Coliphage vB_EcoM_Lh1B as a Promising Therapeutic Agent against Chicken Colibacillosis},
  journal = {Microorganisms},
  year = {2023},
  volume = {11},
  number = {6},
  pages = {1524},
  doi = {10.3390/microorganisms11061524}
}
Kostenlos starten →